ライフサイエンスコーパス: lymphoid irradiation

1 it-antithymocyte globulin and low-dose total lymphoid irradiation (10 fractions).

2 conditioning regimen with 10 doses of total lymphoid irradiation (80 cGy each) plus antithymocyte gl

3 Conditioning with total lymphoid irradiation and anti-T-cell antibodies prevente

4 The combination of total lymphoid irradiation and anti-T-cell antibodies safely i

5 Induction of tolerance with total lymphoid irradiation and anti-T-cell antibodies was depe

6 ransplantation conditioning regimen of total lymphoid irradiation and antithymocyte globulin allowed

7 pients who underwent conditioning with total lymphoid irradiation and antithymocyte globulin, the fra

8 nmyeloablative conditioning regimen of total lymphoid irradiation and antithymocyte serum (TLI/ATS) i

9 ng with nonmyeloablative total body or total lymphoid irradiation and depletive anti-T-cell antibodie

10 Fractionated total lymphoid irradiation and perithymic or intrathymic donor

11 ansplant recipient given pretransplant total lymphoid irradiation and withdrawn from immunosuppressiv

12 studies have shown that posttransplant total lymphoid irradiation, anti-thymocyte globulin, and an in

13 d that Lewis rats given posttransplant total lymphoid irradiation, antithymocyte globulin, and a sing

14 We determined whether total lymphoid irradiation can simultaneously protect against

15 and nonmyeloablative conditioning with total lymphoid irradiation, cyclophosphamide, and rabbit-antit

16 cal and clinical studies of the use of total lymphoid irradiation for the induction of chimeric and n

17 otal marrow irradiation and total marrow and lymphoid irradiation, highlighting both the possible adv

18 use model to test the hypothesis that, after lymphoid irradiation, host CD8(+) DCs play a requisite r

19 Recipients were given 18 Gy total lymphoid irradiation in 16 fractions (1.125 Gy each) ove

20 otal marrow irradiation and total marrow and lymphoid irradiation in multi-centric phase 2-3 trials.

21 total marrow irradiation or total marrow and lymphoid irradiation in new conditioning regimens seems

22 In total lymphoid irradiation-induced allograft tolerance(9,10),

23 from either donors or hosts conditioned with lymphoid irradiation is dependent on their secretion of

24 ntle-cell lymphoma (n = 13) received a total lymphoid irradiation of 80 cGy for 10 days and antithymo

25 splants with clonal deletion protocol (total lymphoid irradiation or bortezomib), and followed with r

26 er intensive accelerated fractionation total lymphoid irradiation or carmustine and ASCT.

27 the high group required treatment with total lymphoid irradiation (P<0.02).

28 in cDC1s impairs tolerance induced by total lymphoid irradiation plus anti-thymocyte serum.

29 A regimen of total lymphoid irradiation plus antithymocyte globulin decreas

30 Conditioning with total lymphoid irradiation plus antithymocyte serum protects m

31 Conditioning with total lymphoid irradiation protected hosts against both graft-

32 tence of the tolerant state using this total lymphoid irradiation protocol.

33 howed previously that nonmyeloablative total lymphoid irradiation/rabbit anti-thymocyte serum (TLI/AT

34 otal marrow irradiation and total marrow and lymphoid irradiation represent more targeted forms of ra

35 laparotomy to treatment with either subtotal lymphoid irradiation (STLI) or combined-modality therapy

36 to II HD were randomly assigned to subtotal lymphoid irradiation (STLI) or VBM chemotherapy and regi

37 cology Group [SWOG] 9133) comparing subtotal lymphoid irradiation (STLI) with combined-modality treat

38 total lymphoid irradiation [TLI] or subtotal lymphoid irradiation [STLI].

39 in mice after conditioning with fractionated lymphoid irradiation (TLI) and anti-T-cell antibodies, a

40 ive conditioning regimen consisting of total lymphoid irradiation (TLI) and anti-T-cell globulin (ATG

41 n Lewis rat hosts given posttransplant total lymphoid irradiation (TLI) and anti-thymocyte globulin (

42 Sixteen patients conditioned with total lymphoid irradiation (TLI) and antithymocyte globulin (A

43 d (47) malignancies received RIC using total lymphoid irradiation (TLI) and antithymocyte globulin (A

44 lative conditioning regimen comprising total lymphoid irradiation (TLI) and antithymocyte globulin is

45 Nonmyeloablative conditioning using total lymphoid irradiation (TLI) and rabbit antithymocyte seru

46 or 4.5 Gy (26 patients) [corrected] of total lymphoid irradiation (TLI) before admission.

47 ning with the nonmyeloablative regimen total lymphoid irradiation (TLI) before hematopoietic cell tra

48 Mice given total lymphoid irradiation (TLI) can be tolerized by an incomp

49 Adult mice treated with total-lymphoid irradiation (TLI) followed by hematopoietic cel

50 The immune modulatory effects of total lymphoid irradiation (TLI) for graft-versus-host disease

51 The immunosuppressive effects of total lymphoid irradiation (TLI) for protection against graft-

52 Total lymphoid irradiation (TLI) has been used in transplantat

53 Total lymphoid irradiation (TLI) has been used to treat rheuma

54 Posttransplant total lymphoid irradiation (TLI) treatment has been applied to

55 Total lymphoid irradiation (TLI) with antithymocyte globulin (

56 d that a combination of posttransplant total lymphoid irradiation (TLI), rabbit antithymocyte globuli

57 afts using a regimen of posttransplant total lymphoid irradiation (TLI), rabbit antithymocyte or anti

58 Rodents and dogs conditioned with total-lymphoid irradiation (TLI), with or without antithymocyt

59 grafts in patients given pretransplant total lymphoid irradiation (TLI).

60 d or extended field) or to both sides (total lymphoid irradiation [TLI] or subtotal lymphoid irradiat

61 this purpose, baboons conditioned with total lymphoid irradiation were given 6 x 10(8) unmodified hum